ZIC
APYX icon

ZWJ Investment Counsel’s Apyx Medical APYX Stock Holding History

ZWJ Investment Counsel’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,258
Closed -$84K – 174
2022
Q2 		$84K Hold
14,258
– – ﹤0.01% 177
2022
Q1 		$93K Hold
14,258
– – ﹤0.01% 175
2021
Q4 		$183K Hold
14,258
– – 0.01% 178
2021
Q3 		$197K Buy
+14,258
New +$150K 0.01% 166

Other funds holding APYX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

ZWJ Investment Counsel's APYX Position: Q3 2022 in Review

ZWJ Investment Counsel sold out of Apyx Medical (APYX) in Q3 2022, closing a stake of 14,258 shares — an estimated $84K sold.

ZWJ Investment Counsel first reported a position in APYX in Q3 2021 and held it in 4 quarters. The position peaked at $197K in Q3 2021. 54 funds tracked by Wall St. Rank hold APYX as of Q3 2022.

  • ZWJ Investment Counsel reported no remaining Apyx Medical position as of Q3 2022 after selling out during the quarter.
  • ZWJ Investment Counsel sold 14,258 Apyx Medical shares in Q3 2022, an estimated $84K.
  • ZWJ Investment Counsel first reported a position in Apyx Medical in Q3 2021 and held it in 4 quarters.
  • ZWJ Investment Counsel's Apyx Medical position peaked at $197K in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2022.

Based on ZWJ Investment Counsel's 13F filing for Q3 2022, filed 19 Oct 2022.